Keyword: Johnson & Johnson

On the heels of a $120 million verdict issued last month, J&J was ordered by a Philadelphia jury to pay $80 million to a woman whose mesh eroded.

The FBI has launched its own probe into some of the world’s largest medtech companies, stemming from a Brazilian corruption case, Reuters reports.

J&J’s electrophysiology-focused Biosense Webster division launched a cloud-based network to link up the field’s myriad devices and share their data.

Twentyeight-Seven will ramp up its cancer programs, develop programs aimed at other types of RNA and apply its work in non-oncology disease areas.

J&J has settled nearly all cases related to surgically removed metal-on-metal hip implants for a total of about $1 billion, according to Bloomberg.

J&J and Boston University scientists identified genomic alterations in the immune system that could lead to early lung cancer development.

Arrowhead Pharmaceuticals will assess ARO-HBV in combination with two undisclosed drugs selected by Johnson & Johnson.

Edwards Lifesciences and Johnson & Johnson Vision Care have made multimillion-euro investments to boost their manufacturing capacity in Ireland.

Fusion Pharmaceuticals raised $105 million to push a clinical-stage program and build a pipeline of new treatments and combination therapies.

Johnson & Johnson Vision has launched its adaptive contacts that darken to match changing light, employing the same tech seen in Transitions lenses.